1.4400
-0.0100
(-0.69%)
As of 12:20:41 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -2.29 | -2.29 |
| Low Estimate | 0 | 0 | -2.29 | -2.29 |
| High Estimate | 0 | 0 | -2.29 | -2.29 |
| Year Ago EPS | -- | -- | -2.32 | -2.29 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.85 | -0.78 | -0.42 | -0.29 |
| EPS Actual | -0.97 | -0.66 | -0.52 | -0.26 |
| Difference | -0.12 | 0.12 | -0.1 | 0.03 |
| Surprise % | -14.39% | 15.60% | -22.51% | 10.20% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -2.29 | -2.29 |
| 7 Days Ago | 0 | 0 | -1.88 | -1.74 |
| 30 Days Ago | 0 | 0 | -1.88 | -1.74 |
| 60 Days Ago | 0 | 0 | -1.81 | -1.67 |
| 90 Days Ago | 0 | 0 | -1.51 | -1.3 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HLVX | -- | -- | 1.49% | 0.00% |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/31/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 8/12/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 7/9/2024 |
| Downgrade | Stifel: Buy to Hold | 7/9/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 7/9/2024 |
| Downgrade | JP Morgan: Overweight to Neutral | 7/8/2024 |
Related Tickers
EPIX ESSA Pharma Inc.
1.5150
-4.10%
THRD Third Harmonic Bio, Inc.
3.3800
-5.31%
TBPH Theravance Biopharma, Inc.
8.46
-3.59%
PMVP PMV Pharmaceuticals, Inc.
0.9600
-3.52%
ASMB Assembly Biosciences, Inc.
8.72
-6.34%
KROS Keros Therapeutics, Inc.
9.93
-3.40%
SPRO Spero Therapeutics, Inc.
0.5968
-4.36%
RPTX Repare Therapeutics Inc.
1.0100
-3.81%
GLTO Galecto, Inc.
2.7250
-4.72%
ANTX AN2 Therapeutics, Inc.
1.2900
-7.86%